![Frank Slack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Slack
Fondatore presso
Impilo Therapeutics, Inc.
Profilo
Frank J.
Slack is the founder of Redona Therapeutics, Inc. founded in 2016.
Dr. Slack is also the founder of Impilo Therapeutics, Inc.,MiraDx, Inc. Dr. Slack is currently a Professor at Yale University.
Posizioni attive di Frank Slack
| Società | Posizione | Inizio |
|---|---|---|
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 05/07/2010 |
Impilo Therapeutics, Inc.
 Impilo Therapeutics, Inc. Packaged SoftwareTechnology Services Develops a platform for delivering nucleic acid-based medicines to solid tumor cancers | Fondatore | - |
Precedenti posizioni note di Frank Slack
| Società | Posizione | Fine |
|---|---|---|
Redona Therapeutics, Inc.
 Redona Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics for cancer and autoimmune diseases | Fondatore | - |
MiraDx, Inc.
 MiraDx, Inc. Medical/Nursing ServicesHealth Services Provides research and testing for cancer treatments | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
97
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MiraDx, Inc.
MiraDx, Inc. Medical/Nursing ServicesHealth Services Provides research and testing for cancer treatments | Health Services |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics for cancer and autoimmune diseases | Health Technology |
Impilo Therapeutics, Inc.
Impilo Therapeutics, Inc. Packaged SoftwareTechnology Services Develops a platform for delivering nucleic acid-based medicines to solid tumor cancers | Technology Services |
